Therefore, it could be hypothesized that these SNPs represent causal risk factors for DCM, as described for the P-glycoprotein encoding gene MCP1 and affected drug and inhibitor interactions [9]. The gene discussed is CCL2; the disease is familial dilated cardiomyopathy.